Umstead John V.
- SEC CIK
- 0001967910
No open-market purchases or sales filed in the past year.
Current role at each company
- GTHX G1 Therapeutics, Inc.Chief Financial Officeras of Sep 18, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Umstead John V. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2024 (view filing) | Jul 5 | 3 days | Umstead John V.Chief Financial Officer | SSale | −527 | $2.51 | −$1.32K | −0.3%187.7K after | |
| May 15, 2024 (view filing) | May 13 | 2 days | Umstead John V.Chief Financial Officer | SSale | −8.15K | $4.79 | −$39.0K | −5.1%153.2K after | |
| Mar 20, 2024 (view filing) | Mar 18 | 2 days | Umstead John V.Chief Financial Officer | SSale | −6.55K | $3.02 | −$19.8K | −5.0%123.9K after | |
| Jan 8, 2024 (view filing) | Jan 3-4 | 5 daysLate | Umstead John V.Chief Financial Officer | SSale | −743 | $3.09 | −$2.30K | −0.6%130.4K after | 3 lots |